Cardioversion for atrial fibrillation: does inflammation matter?
Watson
Timothy
T
Kakar
Puneet
P
Lip
Gregory Y H
GY
D047228:Angiotensin II Type 1 Receptor Blockers / Q000494:pharmacology*; D001281:Atrial Fibrillation / Q000097:blood / Q000503:physiopathology / Q000628:therapy*; D001562:Benzimidazoles / Q000494:pharmacology; D001713:Biphenyl Compounds; D002097:C-Reactive Protein / Q000187:drug effects / Q000378:metabolism; D023201:CD40 Ligand / Q000097:blood / Q000187:drug effects; D019040:E-Selectin / Q000097:blood / Q000187:drug effects; D004554:Electric Countershock; D006329:Heart Conduction System / Q000187:drug effects / Q000378:metabolism / Q000503:physiopathology; D006801:Humans; D018836:Inflammation Mediators / Q000097:blood*; D015850:Interleukin-6 / Q000097:blood; D019007:P-Selectin / Q000097:blood / Q000187:drug effects; D013777:Tetrazoles / Q000494:pharmacology; D014409:Tumor Necrosis Factor-alpha / Q000097:blood / Q000187:drug effects; D019010:Vascular Cell Adhesion Molecule-1 / Q000097:blood / Q000187:drug effects
D047228:Angiotensin II Type 1 Receptor Blockers; D001562:Benzimidazoles; D001713:Biphenyl Compounds; D019040:E-Selectin; D018836:Inflammation Mediators; D015850:Interleukin-6; D019007:P-Selectin; D013777:Tetrazoles; D014409:Tumor Necrosis Factor-alpha; D019010:Vascular Cell Adhesion Molecule-1; D023201:CD40 Ligand; D002097:C-Reactive Protein; C081643:candesartan